MICHAEL TODD MILLER
Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology MONTGOMERY, AL NPI 1891985263
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology AL Abbott Laboratories All categories
General Payments — all program years on this page
$1,257.27
- Category: General Payments
- Program years: PY2018–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $152.54 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.54 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $37.92 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.19 | 1 |
| Janssen Pharmaceuticals, Inc | $20.43 | 1 |
| Kiniksa Pharmaceuticals International, plc | $19.07 | 1 |
| SANOFI-AVENTIS U.S. LLC | $15.50 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.35 | 1 |
| Amgen Inc. | $13.08 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077907485 | Janssen Pharmaceuticals, Inc | $20.43 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1087112926 | Novartis Pharmaceuticals Corporation | $13.35 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115933097 | Amgen Inc. | $13.08 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118223504 | Boehringer Ingelheim Pharmaceuticals, Inc. | $33.19 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125327166 | Abbott Laboratories | $13.28 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125327168 | Abbott Laboratories | $24.64 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140011766 | SANOFI-AVENTIS U.S. LLC | $15.50 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154891421 | Kiniksa Pharmaceuticals International, plc | $19.07 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.